Arimidex Générique est utilisé pour traiter le cancer du sein chez les femmes postménopausées, incluant les femmes aux prises avec une progression de la maladie après un traitement au tamoxifène.
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth ... - GenomeWeb
MDx/CDx Focus: NanoString Kicks off Second PAM50 Validation Study; MDxHealth .
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - Generation NT (US)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayGeneration NT (US)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality Reduction - MarketWatch (press release)
Increased Mammograms Up to 65% Responsible for Breast Cancer Mortality ReductionMarketWatch (press release)Drugs covered include: Abiraterone acetate (Zytiga), Afatinib (Tomtovok), Afimoxifene (TamoGel), Albumin-bound paclitaxel (Abraxane), Anastrozole (Arimidex), Apatinib, Bevacizumab (Avastin), Bosutinib, Capecitabine (Xeloda), Cediranib, .
NanoString Initiates Second Clinical Validation Study for Breast Cancer Assay - EON: Enhanced Online News (press release)
NanoString Initiates Second Clinical Validation Study for Breast Cancer AssayEON: Enhanced Online News (press release)The ABCSG8 study, initiated in 1996, demonstrated that compared to treatment with tamoxifen alone, sequential adjuvant treatment with tamoxifen followed by anastrozole in postmenopausal women with hormone receptor-positive early-stage breast cancer .
Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds ... - Linex Legal (press release) (registration)
Norton Rose Group | Pharma in brief - Canada: Federal Court of Appeal upholds .